|
 |
Cardiovascular Health > Angina
The following information is about Angina.
Angina Defined
Chest pain or chest discomfort; the symptom felt when the heart is not getting enough blood and oxygen. The pain or discomfort may manifest itself in a number of different ways, such as a discomfort, heaviness, tightness, burning, pressure, squeezing or fullness. It may occur in various locations, including under the breastbone or in or around the chest, jaw, neck, arms, upper back or between the shoulder blades. It can also bring about feelings of nausea, shortness of breath, sweating, dizziness or weakness. It is important for those who have angina to respond by taking a prescribed nitroglycerine tablet or spray.
This definition is in context to Cardiovascular Health. See more contextual defintions for Angina.
Are Caffeine Drinks Worth The Energy Boost?
Published September 5, 2008, 11:00 am, The Tampa Tribune
Energy drinks are consumed by people of all ages, but the beverages have been heavily marketed to younger people, prompting questions regarding safety.
Company Profile for Vasomedical, Inc.
Published September 5, 2008, 7:22 am, Centre Daily Times
Vasomedical, Inc. develops, manufactures and markets EECP(R) therapy systems to deliver its proprietary form of enhanced external counterpulsation therapy. EECP(R) therapy is a non-invasive, outpatient therapy used in the treatment of ischemic cardiovascular diseases, currently used to manage chronic stable angina and heart failure. The therapy increases blood flow and oxygen supply to the heart ...
Company Profile for Vasomedical, Inc.
Published September 5, 2008, 7:10 am, Business Wire via Yahoo! Finance
----Vasomedical, Inc. develops, manufactures and markets EECP® therapy systems to deliver its proprietary form of enhanced external counterpulsation therapy. EECP® therapy is a non-invasive, outpatient therapy used in the treatment of ischemic cardiovascular diseases, currently used to manage chronic stable angina and heart failure.
Cytokinetics Announces the Initiation of Third Phase IIa Clinical Trial of CK-1827452
Published September 5, 2008, 4:30 am, Marketwire via Yahoo! Finance
Cytokinetics, Incorporated announced today the initiation of its third Phase IIa clinical trial evaluating CK-1827452, a novel cardiac myosin activator being developed by the company for the potential treatment of patients with either acutely decompensated or chronic heart failure. CK-1827452 is the subject of a Collaboration and Option Agreement between Cytokinetics and Amgen Inc.
Migraine With Aura may be Linked to Increased Risk of Stroke and Heart Attacks and Must be Taken Seriously by GPs
Published September 5, 2008, 2:00 am, PR Newswire via Yahoo! Finance
Doctors need to pay special attention to people with migraine with aura as they could be at increased risk of stroke or heart attack, a London conference heard today .
Lowering heart rate lessens risk of heart attack
Published September 4, 2008, 5:09 am, CTV.ca
Lowering the heart rate of patients with coronary artery disease (CAD) can significantly lessen their risk of heart attack, according to results of a study, announced at the European Society of Cardiology Congress in Munich.
Prasugrel Significantly Reduced New Or Recurrent Heart Attacks In Both Acute And Longer-Term Settings Following PCI, ...
Published September 4, 2008, 3:10 am, Medical News Today
A sub-analysis of the TRITON-TIMI 38 clinical trial showed that treatment with prasugrel compared with clopidogrel significantly reduced the risk of new or recurrent heart attacks (7.4 percent vs. 9.
CV Therapeutics Initiates Phase 1 Clinical Trial Of CVT-3619, A Novel Potential Treatment For Cardiometabolic Diseases
Published September 4, 2008, 3:09 am, Medical News Today
CV Therapeutics, Inc. (Nasdaq: CVTX) announced that the company has enrolled the first patient in a Phase 1 trial of CVT-3619, a novel oral compound for potential treatment of cardiometabolic diseases. The U.S. Food and Drug Administration recently accepted the Company's investigational new drug application for CVT-3619, a partial A1 adenosine receptor agonist.
Breakthrough drug could cut risk of stroke by a third in 700,000 irregular heartbeat sufferers
Published September 3, 2008, 8:10 pm, Daily Mail
Thousands of lives could be saved using a new drug which cuts deaths from a common heart rhythm disorder by almost a third.
Victory at Provincial Election
Published September 3, 2008, 6:45 pm, Daily News
Some narrow minded political observers predicted the defeat of the Government party in the recent provincial election. But, they would have realised their wrong views of the Government by now.
Are you looking for additional Cardiovascular Health > Angina news? Try our new "Angina News Focus" area.
Off-site Angina Links, User Submitted
The following links have been collected through user bookmark submission in the Angina category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Sat Aug 30
- Facts About Angina: Web site provides facts about Angina; including a detailed look at this disorder, the difference between heart attack and angina, diagnosis, treatment, etc.
Sun Aug 24
- Heart Disease Help - Forums and Discussions - MedHelp: This forum is for questions and support regarding heart issues such as: Angina, Angioplasty, Arrhythmia, Bypass Surgery, Cardiomyopathy , Coronary Artery Disease, Defibrillator, Heart Attack, Heart Disease, High Blood Pressure, Mitral Valve, Pacemaker, PAD, Stenosis, Stress Tests
Fri Aug 22
Wed Aug 20
- Pharma Live | Stable Angina | Search Results
- Wiley InterScience :: JOURNALS :: Cardiovascular Drug Reviews: Pitavastatin: Efficacy and Safety Profiles of A Novel Synthetic HMG-CoA Reductase Inhibitor
Tue Aug 19
- Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularizat ion | Clinical Trials | Recruiting
- Stable Angina | Clinical Trials | NextBio
- Angina Clinical Trials | NextBio | Search Results
- NextBio: The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction: The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction
- Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Angina. If you would like to find related tags we recommend Tag Patterns > Angina
Off-site Angina Research Links
If you still need additional information on Angina then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Cardiovascular Health Topics
Everything you need to know about Cardiovascular Health
Cardiovascular Health
If you know the Cardiovascular Health Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Cardiovascular-Health.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.